Literature DB >> 12875755

Determinants of target vessel failure in chronic total coronary occlusions after stent implantation. The influence of collateral function and coronary hemodynamics.

Gerald S Werner1, Philipp Bahrmann, Oliver Mutschke, Ulf Emig, Stefan Betge, Markus Ferrari, Hans R Figulla.   

Abstract

OBJECTIVES: The goal of this study was to assess the influence of collateral function, coronary hemodynamics, and the angiographic result on the risk of target vessel failure (TVF) after recanalization of a chronic total coronary occlusion (CTO).
BACKGROUND: Collaterals may have an adverse effect on TVF.
METHODS: In 111 consecutive patients, a CTO (duration >2 weeks) was successfully recanalized with stent implantation. Collateral function was assessed by intracoronary Doppler flow velocity and pressure recordings distal to the occlusion. Baseline collateral function was determined before the first balloon inflation, and recruitable collateral function after stenting during a balloon reocclusion. Finally, the coronary flow velocity reserve (CFVR) and the fractional flow reserve (FFR) were measured.
RESULTS: Angiographic follow-up after 5 +/- 4 months in 106 patients showed a reocclusion in 17% and a restenosis in 36%. The major determinants of TVF were the stent length (p < 0.01) and number of implanted stents (p < 0.01). No difference was observed in baseline or recruitable collateral function between patients with and without TVF; 52% of patients had a CFVR >or= 2.0, and only 18% a CFVR >or=2.5 after percutaneous transluminal coronary angioplasty, but neither cutoff-value predicted TVF. A low FFR discriminated patients with reocclusion (0.81 +/- 07 vs. 0.86 +/- 08, p < 0.05) but not with restenosis (0.87 +/- 0.06).
CONCLUSIONS: This study showed that there is no relation between a well-developed collateral supply and the risk of TVF in recanalized CTOs. This was rather determined by the stented segment length. There was also no adverse effect of the frequently observed impaired CFVR on TVF, whereas a low FFR was associated with a higher risk of reocclusion.

Entities:  

Mesh:

Year:  2003        PMID: 12875755     DOI: 10.1016/s0735-1097(03)00624-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  [Treatment strategies for chronic total occlusion: current status and outlook].

Authors:  G S Werner
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

2.  Does a well developed collateral circulation predispose to restenosis after percutaneous coronary intervention? An intravascular ultrasound study.

Authors:  D Perera; P Postema; R Rashid; S Patel; L Blows; M Marber; S Redwood
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

3.  Recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion.

Authors:  G S Werner; U Emig; P Bahrmann; M Ferrari; H R Figulla
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

4.  Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice.

Authors:  Gerald S Werner; Anselm K Gitt; Uwe Zeymer; Claus Juenger; Frank Towae; Harm Wienbergen; Jochen Senges
Journal:  Clin Res Cardiol       Date:  2009-03-18       Impact factor: 5.460

5.  A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions.

Authors:  Nicolas Lamblin; François J Cuilleret; Nicole Helbecque; Jean Dallongeville; Jean-Marc Lablanche; Philippe Amouyel; Christophe Bauters; Eric Van Belle
Journal:  BMC Cardiovasc Disord       Date:  2005-09-15       Impact factor: 2.298

Review 6.  CTO pathophysiology: how does this affect management?

Authors:  John Irving
Journal:  Curr Cardiol Rev       Date:  2014-05

7.  Prompt and consistent improvement of coronary flow velocity reserve following successful recanalization of the coronary chronic total occlusion in patients with viable myocardium.

Authors:  Milan Dobric; Branko Beleslin; Milorad Tesic; Ana Djordjevic Dikic; Sinisa Stojkovic; Vojislav Giga; Miloje Tomasevic; Ivana Jovanovic; Olga Petrovic; Jelena Rakocevic; Nikola Boskovic; Dragana Sobic Saranovic; Goran Stankovic; Vladan Vukcevic; Dejan Orlic; Dragan Simic; Milan A Nedeljkovic; Srdjan Aleksandric; Stefan Juricic; Miodrag Ostojic
Journal:  Cardiovasc Ultrasound       Date:  2020-07-21       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.